Azetidin-3-ylmethanamine dihydrochloride

Catalog No.: 
ACKYBE651
CAS No.: 
221095-80-3
Molecular Formula: 
C4H12Cl2N2
Molecular Weight: 
159.06
Azetidin-3-ylmethanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$52.00In stockInquiry
5g97%$202.00In stockInquiry
10g97%$339.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAzetidin-3-ylmethanamine dihydrochloride
IUPAC Nameazetidin-3-ylmethanamine dihydrochloride
MDL No.MFCD10565803
Molecular FormulaC4H12Cl2N2
Molecular Weight159.06
SMILESNCC1CNC1.[H]Cl.[H]Cl
InChI KeyQQAHPBUCLORFBD-UHFFFAOYSA-N
SynonymAzetidin-3-ylmethanamine dihydrochloride | 221095-80-3 | 3-Azetidinemethanamine dihydrochloride | 3-(aminomethyl)azetidine dihydrochloride | azetidin-3-ylmethanamine;dihydrochloride | MFCD10565803 | 3-Aminomethyl-azetidine dihydrochloride | Azetidin-3-ylmethanaminedihy
CAS No.221095-80-3
PubChem CID22121283

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKYBE651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLQVX603 route compound structure diagram
    ACLQVX603325775-44-8In Stock
  2. Then
  3. ACKYBE651 route product structure diagram
    ACKYBE651221095-80-3In Stock
Inquiry

2. ACKYBE651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHSXT715 route compound structure diagram
    ACHSXT71591188-15-7In Stock
  2. Then
  3. ACKYBE651 route product structure diagram
    ACKYBE651221095-80-3In Stock
Inquiry

3. ACKYBE651 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKYBE651 route product structure diagram
    ACKYBE651221095-80-3In Stock
Inquiry

Comments (0)